These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16900754)

  • 1. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis.
    Correale J; Tenembaum SN
    Mult Scler; 2006 Aug; 12(4):412-20. PubMed ID: 16900754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes.
    Correale J; de los Milagros Bassani Molinas M
    J Neuroimmunol; 2003 Mar; 136(1-2):162-71. PubMed ID: 12620656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.
    Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R
    Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis.
    Traggiai E; Biagioli T; Rosati E; Ballerini C; Mazzanti B; Ben Nun A; Massacesi L; Vergelli M
    J Neuroimmunol; 2001 Dec; 121(1-2):111-9. PubMed ID: 11730947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
    Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
    Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity.
    Hellings N; Gelin G; Medaer R; Bruckers L; Palmers Y; Raus J; Stinissen P
    J Neuroimmunol; 2002 May; 126(1-2):143-60. PubMed ID: 12020966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
    Bischof F; Bins A; Dürr M; Zevering Y; Melms A; Kruisbeek AM
    J Immunol; 2004 Jul; 173(1):600-6. PubMed ID: 15210822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse.
    Sáez-Torres I; Brieva L; Espejo C; Barrau MA; Montalban X; Martínez-Caceres EM
    Autoimmunity; 2002 Feb; 35(1):45-50. PubMed ID: 11908706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
    Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.
    Harp CT; Ireland S; Davis LS; Remington G; Cassidy B; Cravens PD; Stuve O; Lovett-Racke AE; Eagar TN; Greenberg BM; Racke MK; Cowell LG; Karandikar NJ; Frohman EM; Monson NL
    Eur J Immunol; 2010 Oct; 40(10):2942-56. PubMed ID: 20812237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.
    Dhib-Jalbut S; Chen M; Said A; Zhan M; Johnson KP; Martin R
    J Neuroimmunol; 2003 Jul; 140(1-2):163-71. PubMed ID: 12864985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
    Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
    Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.